Vir Biotechnology (VIR) Interest Expenses (2018 - 2026)
Vir Biotechnology (VIR) reported Interest Expenses of $685000.0 for Q1 2026, up 1493.02% on a YoY basis from $43000.0 in Q1 2025, and up 3325.0% sequentially from $20000.0 in Q4 2025.
Vir Biotechnology (VIR) Interest Expenses (2018 - 2026) Analysis & Trends
Vir Biotechnology (VIR) has 9 years of Interest Expenses data on file, last reported at $685000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 1493.02% year-over-year to $685000.0; the trailing twelve-month figure through Mar 2026 stood at $685000.0 (up 1493.02% YoY), and the FY2025 full-year result was $527.1 million, up 16.26% from the prior year.
- Interest Expenses rose to $685000.0 in Q1 2026, from $20000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $453.4 million in Q4 2024 to a low of $12000.0 in Q1 2024.
- A 5-year average of $97.9 million and a median of $1.1 million in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses slumped 100.0% in 2025 and soared 1493.02% in 2026, its largest moves.
- Tracing VIR's Interest Expenses over 5 years: stood at $204.6 million in 2022, then surged by 74.4% to $356.8 million in 2023, then climbed by 27.06% to $453.4 million in 2024, then tumbled by 100.0% to $20000.0 in 2025, then surged by 3325.0% to $685000.0 in 2026.
- Business Quant data shows VIR's Interest Expenses at $685000.0 in Q1 2026, $20000.0 in Q4 2025, and $67000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Vir Biotechnology | 1.28 Bn | 1.28 Bn | - | 685,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 685,000.00 |
| Mar 31, 2026 | 685,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | 453.39 Mn |
| Dec 31, 2024 | 453.39 Mn |
| Sep 30, 2024 | 27,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 356.83 Mn |
| Dec 31, 2023 | 356.83 Mn |